Anzeige
Mehr »
Freitag, 10.04.2026 - Börsentäglich über 12.000 News
Research Capital bestätigt $3,00 Kursziel - FUTR zündet die nächste Stufe: Vom Fintech zur globalen Finanzplattform
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von x3news

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
20.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
19.03.CB First Investment Bank AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
19.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
18.03.Shelly Group SE: Annual financial report
18.03.CB First Investment Bank AD: Sustainability information
18.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
17.03.CB First Investment Bank AD: Consolidated annual financial report
17.03.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
16.03.Advance Terrafund REIT: Other unregulated information
13.03.Telelink Business Services Group AD: Other unregulated information
13.03.Telelink Business Services Group AD: Other unregulated information
12.03.Telelink Business Services Group AD: Other unregulated information
11.03.Venus AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
11.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.03.Bulgarian Real Estate Fund REIT: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.03.IPO Growth AD: Other unregulated information
09.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
05.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014